Literature DB >> 31101565

For whom the bell tolls? It is time to retire the classic BPD (bilio-pancreatic diversion) operation.

Michel Gagner1.   

Abstract

With the culture of safety and lowering risks that took place 20 years ago, sleeve gastrectomy has emerged as a procedure of choice. Hence, for super- and super-super-obese patients, there is a tendency these days to perform surgeries in 2 stages, and sleeve is the procedure of choice. Because sleeve is not part of a classic bilio-pancreatic diversion, it is unlikely that this operation will be done as a second stage, making this operation obsolete.
Copyright © 2019 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biliopancreatic diversion; Scopinaro; duodenal switch; malabsoprtive surgery; malabsorption; sleeve gastrectomy; weight loss surgery

Mesh:

Year:  2019        PMID: 31101565     DOI: 10.1016/j.soard.2019.03.029

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  3 in total

1.  Biliopancreatic Diversion in the Surgical Treatment of Morbid Obesity: Long-Term Results and Metabolic Consequences.

Authors:  Alessandro Bianchi; Alberto Pagan-Pomar; Marina Jimenez-Segovia; José Antonio Martinez-Corcoles; Francesc Xavier Gonzalez-Argenté
Journal:  Obes Surg       Date:  2020-06-19       Impact factor: 4.129

2.  COMPLICATIONS AND LATE FOLLOW-UP OF SCOPINARO'S SURGERY WITH GASTRIC PRESERVATION: 1570 PATIENTS OPERATED IN 20 YEARS.

Authors:  Paula Volpe; Carlos Eduardo Domene; André Valente Santana; William Giglio Mira; Marco Aurélio Santo
Journal:  Arq Bras Cir Dig       Date:  2022-06-17

3.  Bariatric Surgery for Hypothalamic Obesity in Craniopharyngioma Patients: A Retrospective, Matched Case-Control Study.

Authors:  Selveta S van Santen; Peter Wolf; Natalia Kremenevski; Cesar L Boguszewski; Hannes Beiglböck; Marta Fiocco; Mark Wijnen; Ville R Wallenius; Marry M van den Heuvel-Eibrink; Aart J van der Lely; Gudmundur Johannsson; Anton Luger; Michael Krebs; Michael Buchfelder; Patric J D Delhanty; Sebastian J C M M Neggers; Daniel S Olsson
Journal:  J Clin Endocrinol Metab       Date:  2021-10-21       Impact factor: 5.958

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.